Toxicity and dose intensity of FOLFOX in patients with increased body mass index
Version 2 2024-06-03, 22:16Version 2 2024-06-03, 22:16
Version 1 2015-04-29, 15:05Version 1 2015-04-29, 15:05
journal contribution
posted on 2014-01-01, 00:00authored byS N Suibhne, F King, V Treacy, J Kennedy, Ian CollinsIan Collins, A E Weidmann
This study was conducted at St James‘s Hospital, Dublin, Ireland, in 2010. It evaluated the dose intensity and toxicities experienced by patients of normal and increased body mass index treated with FOLFOX chemotherapy, and demonstrated that overweight patients may tolerate doses based on actual body weight.
History
Journal
European Journal of Oncology Pharmacy
Volume
8
Issue
1
Pagination
14 - 18
ISSN
1783-3914
Publication classification
C Journal article; C3.1 Non-refereed articles in a professional journal